Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of acute myeloid leukemia relapsing after autologous stem cell transplantation. Ann Hematol 1999;78:380-384.Ferrara, F. , Melillo, L. , Montillo, M. , Leoni, F. , Pinto, A. , Mele, G. & Mirto, S. ( 1999 ) Fludarabine,...
Fludarabine, cytarabine, and G‐CSF (FLAG) for the treatment of poor risk acute myeloid leukemia Thirty-eight patients with primary resistant or relapsing acute myeloid leukemia (AML) were treated with fludarabine, cytarabine and granulocyte colony-sti... M Montillo,S Mirto,MC Petti,... - 《...
5、onclusions: FLAG program is a better choice for relapse or refractory patients with acute myelogenous leukemia. KEY WORDS Acute myeloid leukemia; Relapse; Refractory; Fludarabine 复发或难治性急性髓系白血病(acute myeloid leukemia, AML)患者疗效不佳,预后差。氟达拉滨(Flu)属氟化嘌呤类似物免疫抑制...
leukemia associated with immunophenotype,final comparing with bone marrow morphology.Results Hematologic toxicity was similar both in the treatment group and control group.Nonhematology complications consisted of heart and liver toxicity (1/20 and 9/20) were weaker than those in control group (4/20 ...
FLAG和MEA方案治疗难治复发性急性髓系白血病的Meta分析
Treatment outcome of FLAG regimen for the refractory and relapsed acute leukemia FLAG方案治疗难治复发性急性白血病的临床观察 4. Clinical Analysis of FLAG Regimen in the Treatment of Relapsed/refractory Acute Myeloid Leukemia; FLAG方案治疗复发/难治急性髓系白血病的临床病例分析 ...
Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of acute myeloid leukemia relapsing after autologous stem cell transplantation Twenty-six patients affected by acute myeloid leukemia (AML) who relapsed after autologous stem cell transplantation (ASCT) were treated with the FLAG regi... F...
复发性,难治性急性白血病(acute leukemia,AL)缓解率低,治疗效果差,是目前临床治疗中的难题,积极探索和寻找更好,更优化的化疗方案十分必要.国外报道,采用去甲氧柔红霉... 李杰平,曾东风,陈幸华,... - 《西部医学》 被引量: 10发表: 2010年 FLAG方案治疗成年人复发难治性急性淋巴细胞白血病的疗效观察 Objective...
结论 FLAG方案治疗儿童复发性ALL及NHL疗效显著,尤其对于晚期复发患儿疗效较好;不良反应可以耐受.%Objective To evaluate the short-term efficacy and safety of FLAG regime for relapsed childhood acute lymphoblastic leukemia (ALL) and non-Hodgkin's lymphoma (NHL). Methods Retrospective analysis of 19 patient...
A treatment commonly used as a salvage regimen for relapsed/refractory acute myelogenous leukemia (AML) showed better results than did standard treatment when used as initial induction therapy.